KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Rigel Pharmaceuticals (RIGL) Long-Term Debt Repayments: 2009-2011

Historic Long-Term Debt Repayments for Rigel Pharmaceuticals (RIGL) over the last 1 years, with Dec 2011 value amounting to $134,000.

  • Rigel Pharmaceuticals' Long-Term Debt Repayments rose 197.78% to $134,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $800,000, marking a year-over-year decrease of 59.62%. This contributed to the annual value of $800,000 for FY2011, which is 30.07% down from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Long-Term Debt Repayments stood at $134,000 for Q4 2011, which was down 25.97% from $181,000 recorded in Q3 2011.
  • Rigel Pharmaceuticals' Long-Term Debt Repayments' 5-year high stood at $883,000 during Q4 2009, with a 5-year trough of $45,000 in Q4 2010.
  • Over the past 3 years, Rigel Pharmaceuticals' median Long-Term Debt Repayments value was $234,000 (recorded in 2011), while the average stood at $285,286.
  • Its Long-Term Debt Repayments has fluctuated over the past 5 years, first tumbled by 94.90% in 2010, then soared by 197.78% in 2011.
  • Quarterly analysis of 3 years shows Rigel Pharmaceuticals' Long-Term Debt Repayments stood at $883,000 in 2009, then slumped by 94.90% to $45,000 in 2010, then spiked by 197.78% to $134,000 in 2011.
  • Its Long-Term Debt Repayments was $134,000 in Q4 2011, compared to $181,000 in Q3 2011 and $234,000 in Q2 2011.